A sample of the decisions we've helped de-risk across sectors and markets. Details are anonymised and illustrative of the kind of work we do; we share named references under NDA on request.
Challenge. Sales were flat despite strong awareness. The team assumed a pricing problem.
Approach. A U&A wave plus in-home ethnography across six cities, reconciled against shopper data.
Outcome. The issue was pack format, not price. A relaunch in the recommended SKU sizes returned the brand to growth within two quarters.
Challenge. A launch team needed to know which messages moved prescribing intent — and which broke compliance.
Approach. KOL interviews and a physician conjoint across five markets under pharmacovigilance-aligned protocols.
Outcome. A message hierarchy the medical-legal team could sign off, and a country-by-country adoption forecast with stated uncertainty.
Challenge. Downloads were high; active usage was not. Leadership suspected UX.
Approach. Behavioural segmentation plus diary studies capturing the moment users chose cash over the app.
Outcome. Trust, not usability, was the barrier. A staged reassurance programme lifted 30-day retention meaningfully.
Challenge. A grocer wanted to expand private label without cannibalising its hero lines.
Approach. MaxDiff and TURF to optimise the range, with a choice simulator handed to the category team.
Outcome. A tighter, better-reaching assortment the team could stress-test long after the study closed.
Challenge. Stated intent to switch to electric was high, but showroom conversion lagged.
Approach. Path-to-purchase mapping and implicit testing across the consideration journey.
Outcome. Three concrete friction points at the dealer stage, and a revised journey that narrowed the say-do gap.
Challenge. A health programme needed to reach low-connectivity, multilingual populations without bias.
Approach. A hybrid CATI / CAPI design in five languages with careful quota and weighting controls.
Outcome. A representative baseline that survived scrutiny, and message testing that improved recall in the field.
These summaries are representative and anonymised for confidentiality. We're happy to walk through comparable, named work relevant to your category and markets under a mutual NDA.
Let's begin
Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.
Brief us on a study